1. Market Research
  2. > Biotechnology Market Trends
  3. > Biotechnology Analysis & Statistics, June 2017 (p4)

Biotechnology Analysis & Statistics, June 2017 (p4)

24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Publishers

All regions

91-120 of about 3400 reports

Purchase Reports From Reputable Market Research Publishers

T Cell Surface Glycoprotein CD4 (T Cell Surface Antigen T4/Leu 3 or CD4) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

T Cell Surface Glycoprotein CD4 (T Cell Surface Antigen T4/Leu 3 or CD4) - Pipeline Review, H1 2017 Summary According to the recently published report 'T Cell Surface Glycoprotein CD4 - Pipeline Review, ...

  • Industries : Therapy, Pathology
  • Countries : United States, World

N Sulphoglucosamine Sulphohydrolase (Sulfoglucosamine Sulfamidase or Sulphamidase or SGSH or EC 3.10.1.1) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

N Sulphoglucosamine Sulphohydrolase (Sulfoglucosamine Sulfamidase or Sulphamidase or SGSH or EC 3.10.1.1) - Pipeline Review, H1 2017 Summary According to the recently published report 'N Sulphoglucosamine ...

  • Industries : Therapy, Biological Therapy, Pathology, Pharmaceutical, Drug Discovery and Development
  • Countries : United States

T Cell Specific Surface Glycoprotein CD28 (TP44 or CD28) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

T Cell Specific Surface Glycoprotein CD28 (TP44 or CD28) - Pipeline Review, H1 2017 Summary T Cell Specific Surface Glycoprotein CD28 (TP44 or CD28) - CD28 is a proteins expressed on T cells. It co-stimulates ...

  • Industries : Therapy, Biological Therapy, Drug Discovery and Development, Pathology
  • Countries : World, United States

Alpha L-Iduronidase (IDUA or EC 3.2.1.76) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Alpha L-Iduronidase (IDUA or EC 3.2.1.76) - Pipeline Review, H1 2017 Summary Alpha L-Iduronidase (IDUA or EC 3.2.1.76) pipeline Target constitutes close to 9 molecules. Out of which approximately 7 molecules ...

  • Industries : Therapy, Pathology, Biopharmaceutical, Pharmaceutical, Biotechnology, Biological Therapy
  • Countries : United States, World

Protein Phosphatase 2A (PP2A or EC 3.1.3.16) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Protein Phosphatase 2A (PP2A or EC 3.1.3.16) - Pipeline Review, H1 2017 Summary According to the recently published report 'Protein Phosphatase 2A - Pipeline Review, H1 2017'; Protein Phosphatase 2A (PP2A ...

  • Industries : Therapy, Pathology, Cancer
  • Countries : United States

Toll Like Receptor 3 (CD283 or TLR3) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Toll Like Receptor 3 (CD283 or TLR3) - Pipeline Review, H1 2017 Summary Toll Like Receptor 3 (CD283 or TLR3) pipeline Target constitutes close to 14 molecules. Out of which approximately 10 molecules are ...

  • Industries : Pathology, Cancer
  • Countries : World, United States

Integrin Beta 1 (Fibronectin Receptor Subunit Beta or Glycoprotein Iia or VLA 4 Subunit Beta or CD29 or ITGB1) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Integrin Beta 1 (Fibronectin Receptor Subunit Beta or Glycoprotein Iia or VLA 4 Subunit Beta or CD29 or ITGB1) - Pipeline Review, H1 2017 Summary According to the recently published report 'Integrin Beta ...

  • Industries : Therapy, Health Services, Pathology, Pharmaceutical, Biopharmaceutical
  • Countries : World, United States

Melanocyte Protein PMEL (ME20M or Melanocyte Protein Pmel 17 or Melanocytes Lineage Specific Antigen GP100 or Melanoma Associated ME20 Antigen or P1 or P100 or Premelanosome Protein or Silver Locus Protein Homolog or PMEL) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Melanocyte Protein PMEL (ME20M or Melanocyte Protein Pmel 17 or Melanocytes Lineage Specific Antigen GP100 or Melanoma Associated ME20 Antigen or P1 or P100 or Premelanosome Protein or Silver Locus Protein ...

  • Industries : Therapy
  • Countries : United States

Human Cytomegalovirus Envelope Glycoprotein B (gB) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Human Cytomegalovirus Envelope Glycoprotein B (gB) - Pipeline Review, H1 2017 Summary Human Cytomegalovirus Envelope Glycoprotein B (gB) - Human Cytomegalovirus envelope glycoprotein B plays an important ...

  • Industries : Pathology, Therapy
  • Countries : United States

Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase Alfa or GAA or EC 3.2.1.20) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • May 2017
  • by Global Markets Direct

Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase Alfa or GAA or EC 3.2.1.20) - Pipeline Review, H1 2017 Summary Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase Alfa or GAA or EC 3.2.1.20) ...

  • Industries : Therapy, Pathology, Pharmaceutical
  • Countries : United States, World

Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • May 2017
  • by Global Markets Direct

Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Pipeline Review, H1 2017 Summary According to the recently published ...

  • Industries : Cancer, Pathology, Biological Therapy, Therapy
  • Countries : United States, World

Transforming Growth Factor Beta 2 (BSC1 Cell Growth Inhibitor or Cetermin or Glioblastoma Derived T Cell Suppressor Factor or Polyergin or TGFB2) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • May 2017
  • by Global Markets Direct

Transforming Growth Factor Beta 2 (BSC1 Cell Growth Inhibitor or Cetermin or Glioblastoma Derived T Cell Suppressor Factor or Polyergin or TGFB2) - Pipeline Review, H1 2017 Summary According to the recently ...

  • Industries : Pathology, Therapy, Health Services, Cancer
  • Countries : World

Top 50 Companies in Point-of-Care Diagnostic Testing

  • $ 3500
  • Industry report
  • May 2017
  • by Kalorama Information

The POC market is considered evolving with growthopportunity.   Developing and developedmarkets alike have room to grow due to an aging population worldwide.  Key companies such as Roche, LifeScan,Abbott, ...

  • Industries : Diagnostics
  • Countries : World

US Market Report for Dental Bone Graft Substitutes 2017 - MedCore

  • $ 3495
  • Industry report
  • July 2017
  • by iData Research, Inc.

General Report Contents - Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends - Market Drivers & Limiters for each chapter segment - Competitive Analysis for each chapter segment - ...

  • Industries : Advanced Material, Biomaterial, Biomaterial
  • Countries : United States

Global Biosimilar Monoclonal Antibodies Forecast 2017-2027

  • $ 3247
  • Industry report
  • May 2017
  • by Visiongain

Report Details The global biosimilar monoclonal antibodies market is expected to grow at a CAGR of 9.6% in the second half of the forecast period. The market is expected to grow at a CAGR of 23.8% from ...

  • Industries : Therapy
  • Countries : World

Global Biosimilars and Follow-On Biologics Market 2017-2027

  • $ 3247
  • Industry report
  • May 2017
  • by Visiongain

Report Details The global biosimilars and follow-on biologics market is expected to grow at a CAGR of 38.8% in the first half of the forecast period and CAGR of 11.3% in the second half of the forecast ...

  • Industries : Biopharmaceutical, Generic Drug, Therapy, Biotechnology
  • Countries : Europe, World

Global Erythropoietin Market Forecast 2017-2027

  • $ 3247
  • Industry report
  • April 2017
  • by Visiongain

Report Details The global erythropoietin market is expected to grow at a CAGR of 7.8% in the first half of the forecast period and CAGR of 4.8% in the second half of the forecast period. The market is ...

  • Industries : Biopharmaceutical
  • Countries : World

Global Monoclonal Antibody Partnering Terms and Agreements 2010 - 2016: Deal trends, players and financials

  • $ 2995
  • Industry report
  • May 2017
  • by Currentpartnering

The Global Monoclonal Antibody Partnering Terms and Agreements 2010 to 2017 report provides comprehensive understanding and unprecedented access to the monoclonal antibodies partnering deals and agreements ...

  • Industries : Therapy, Pharmaceutical, Pathology, Biotechnology, Oncology, Healthcare
  • Countries : United States

Global Vaccine Partnering Terms and Agreements 2010 - 2016: Deal trends, players and financials

  • $ 2995
  • Industry report
  • May 2017
  • by Currentpartnering

The Global Vaccine Partnering Terms and Agreements 2010-2017: Deal trends, players and financials report provides comprehensive understanding and unprecedented access to the vaccine partnering deals and ...

  • Industries : Therapy, Pharmaceutical, Pathology, Healthcare, Biotechnology
  • Countries : United States, North America

Global Biotech Partnering Terms and Agreements 2010 - 2016: Deal trends, players and financials

  • $ 2995
  • Industry report
  • May 2017
  • by Currentpartnering

Global Biotech Partnering Terms and Agreements 2010 to 2017 report provides a detailed understanding and analysis of how and why companies enter Biotech partnering deals Description Global Biotech Partnering ...

  • Industries : Therapy
  • Countries : United States

Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010 to 2016

  • $ 2995
  • Industry report
  • May 2017
  • by Currentpartnering

The Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2017 report provides comprehensive understanding and unprecedented access to the distribution partnering ...

  • Industries : Pharmaceutical, Healthcare, Biotechnology, Diagnostics, Therapy
  • Countries : United States, North America

Gene Therapy Ophthalmology Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape, 2017

  • $ 2950
  • Industry report
  • July 2017
  • by Delve Insight

DelveInsight’s report, “Gene Therapy Ophthalmology Insight - Pipeline Assessment, Market Trend, Technology and Competitive Landscape, 2017” emphasizes on the currently under development Gene Therapy ...

  • Industries : Biological Therapy

Natural Killer Cells -Competitive Landscape, Technology and Pipeline Analysis, 2017

  • $ 2750
  • Industry report
  • July 2017
  • by Delve Insight

DelveInsight’s, “Natural Killer Cells- Competitive Landscape, Pipeline and Market Analysis, 2017”, report provides comprehensive insights about marketed and pipeline drugs across this Mechanism of ...

  • Industries : Therapy, Biological Therapy

Pancreatic Cancer - Pipeline Review, H1 2017

  • $ 2500
  • Company report
  • June 2017
  • by Global Markets Direct

Pancreatic Cancer - Pipeline Review, H1 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Pancreatic Cancer - Pipeline Review, H1 2017, provides an overview ...

  • Industries : Cancer, Pathology
  • Countries : United States, North America

Parkinson’s Disease - Pipeline Review, H1 2017

  • $ 2500
  • Company report
  • June 2017
  • by Global Markets Direct

Parkinson’s Disease - Pipeline Review, H1 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Parkinson’s Disease - Pipeline Review, H1 2017, provides ...

  • Industries : Pathology, Mental Health
  • Countries : United States

Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H1 2017

  • $ 2500
  • Company report
  • June 2017
  • by Global Markets Direct

Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H1 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Human Immunodeficiency Virus ...

  • Industries : Pathology, Healthcare
  • Countries : United States

Rheumatoid Arthritis - Pipeline Review, H1 2017

  • $ 2500
  • Company report
  • June 2017
  • by Global Markets Direct

Rheumatoid Arthritis - Pipeline Review, H1 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Rheumatoid Arthritis - Pipeline Review, H1 2017, provides an ...

  • Industries : Pathology, Chronic Disease
  • Countries : United States

Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2017

  • $ 2500
  • Company report
  • June 2017
  • by Global Markets Direct

Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Multiple Myeloma (Kahler Disease) - Pipeline Review, ...

  • Industries : Cancer, Pathology, Healthcare
  • Countries : United States

Ovarian Cancer - Pipeline Review, H1 2017

  • $ 2500
  • Company report
  • June 2017
  • by Global Markets Direct

Ovarian Cancer - Pipeline Review, H1 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Ovarian Cancer - Pipeline Review, H1 2017, provides an overview of ...

  • Industries : Cancer, Pathology
  • Countries : United States, North America

Melanoma - Pipeline Review, H1 2017

  • $ 2500
  • Company report
  • June 2017
  • by Global Markets Direct

Melanoma - Pipeline Review, H1 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Melanoma - Pipeline Review, H1 2017, provides an overview of the Melanoma ...

  • Industries : Therapy, Cancer, Pathology, Pharmaceutical, Biotechnology
  • Countries : United States, North America

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.